Breast Cancer Clinical Trials in Philadelphia, PA

Breast Cancer Clinical Trials in Philadelphia, PA

View the best 10 breast cancer medical studies in Philadelphia, Pennsylvania. Access promising new therapies by applying to a Philadelphia-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Philadelphia, Pennsylvania

Here are the top 10 medical studies for breast cancer in Philadelphia, Pennsylvania

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Laboratory Biomarker Analysis

Recruiting1 awardPhase 2
This trial will study using F-18 16 alpha-fluoroestradiol positron emission tomography/computed tomography to see if it can help predict response to endocrine therapy in patients with newly diagnosed breast cancer.
Image of University of Colorado at Denver/ Department of Surgery in Aurora, United States.

Conjugated Estrogens/Bazedoxifene

Hormone Therapy

Recruiting2 awardsPhase 2
This trial is testing whether the study drug Duavee can help treat symptoms of menopause and reduce the risk of developing breast cancer in women with a condition called ductal carcinoma in situ (DCIS).
Image of University of Alabama at Birmingham in Birmingham, United States.

Oral Paclitaxel + Encequidar + Dostarlimab (TSR-042) + Carboplatin with or without trastuzumab +8 More

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing new drugs for breast cancer and trying to find which early indicators predict success for different types of tumors.
Image of Hackensack Meridian Health - John Theurer Cancer Center in Hackensack, United States.

IORT with CT-Guided HDR Brachytherapy

Brachytherapy

Recruiting1 award3 criteria
This trial is testing a new way to give radiation therapy to people with early-stage breast cancer.
Image of M D Anderson Cancer Center in Houston, United States.

Hypofractionated Radiation Therapy +1 More

Radiation Therapy

Recruiting1 awardPhase 2
This trial is comparing two different treatment schedules for women who need radiation therapy to their lymph nodes as part of their breast cancer treatment. One schedule takes 6 weeks and the other takes 4 weeks. The purpose of the trial is to see if the shorter schedule will lower the risk of developing arm swelling, also known as lymphedema, after radiation treatment.
Image of Banner Health/Banner Research in Phoenix, United States.

Quality-of-Life Assessment

Recruiting1 award3 criteria
This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.
Image of University of California, San Francisco in San Francisco, United States.

Atorvastatin +1 More

HMG-CoA reductase inhibitor

Recruiting2 awardsPhase 2
This trial is testing whether the cholesterol-lowering medication atorvastatin can reduce the risk of breast cancer.
Image of Hartford Healthcare Cancer Institute @ Hartford Hospital in Hartford, United States.

Capecitabine +1 More

Anti-metabolites

Recruiting1 awardPhase 1 & 2
This trial is testing a new combination of drugs to treat HER2 positive breast cancer. The drugs are neratinib and capecitabine. The researchers want to see if this new combination is safe and if it has any effect on people with this type of cancer.
Image of Alta Bates Summit Medical Center-Herrick Campus in Berkeley, United States.

Intraoperative Radiation Therapy

Brachytherapy

Recruiting1 award2 criteria
This trial is testing a new way to give radiation therapy for breast cancer that may be as effective as the standard way, and has fewer side effects.
Image of Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital in Washington, United States.

Palbociclib

CDK4/6 Inhibitor

Recruiting1 awardPhase 2
This trial is to see if continuing treatment with palbociclib and adding fulvestrant helps people with hormone-receptor positive breast cancer who have progressed on palbociclib and an aromatase inhibitor.

Popular filter options for breast-cancer philadelphia trials

Phase 3 Clinical Trials

View 100 phase 3 medical studies.

Clinical Trials With No Placebo

View 100 medical studies that do not have a placebo group.

View More Breast-cancer Philadelphia Trials

See another 83 medical studies focused on breast-cancer philadelphia.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.